Thermo Fisher and the new variant
Pinpointing new forms of the coronavirus could be vital, particularly if it mutates in response to vaccination, the company says.
A tale of two Covids for smaller device makers
The pandemic provided the best and worst of times for smid-cap medtechs.
Telemedicine and the “Zoom effect” boost big-cap medtech
In the second half of 2020 medtech began a tentative – and possibly short-lived – recovery.
Atyr’s Covid-19 benefit claims raise questions
The group has blamed placebo “overperformance” on a high proportion of less-sick patients.
Clinical developments over the Christmas period
Trial results in Covid-19 and cancer emerge, but little promise is seen.
Europe backs Pfizer/Biontech Covid-19 vaccine's broad applicability
An extraordinary meeting of the EU CHMP recommends conditional approval of Pfizer/Biontech’s Covid-19 vaccine.
Thermo Fisher and the new variant
Pinpointing new forms of the coronavirus could be vital, particularly if it mutates in response to vaccination, the company says.
A tale of two Covids for smaller device makers
The pandemic provided the best and worst of times for smid-cap medtechs.
Telemedicine and the “Zoom effect” boost big-cap medtech
In the second half of 2020 medtech began a tentative – and possibly short-lived – recovery.
Atyr’s Covid-19 benefit claims raise questions
The group has blamed placebo “overperformance” on a high proportion of less-sick patients.
Clinical developments over the Christmas period
Trial results in Covid-19 and cancer emerge, but little promise is seen.
Europe backs Pfizer/Biontech Covid-19 vaccine's broad applicability
An extraordinary meeting of the EU CHMP recommends conditional approval of Pfizer/Biontech’s Covid-19 vaccine.
